ArticleScientific reports2026
Evaluating the significance of platelet count, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in critically ill children.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When critically ill pediatric patients are admitted to the pediatric intensive care unit (PICU), they may face significant morbidity and mortality. Therefore, it is essential to identify at-risk patients early to manage their conditions promptly and navigate through the complexities of their illnesses. This study aims to evaluate the prognostic value of platelet count, Neutrophil/Lymphocyte ratio (NLR) and the Platelets/Lymphocyte ratio (PLR) in children undergoing medical care in the PICU.Over a period of 6 months, a prospective study involving 91 PICU patients was conducted. Upon admission, patients underwent detailed history-taking, comprehensive systemic evaluations, and standard laboratory tests that encompassed complete blood counts, C-reactive protein levels, coagulation profiles, as well as liver and kidney function assessments. Subsequently, the NLR and PLR values were determined. The median NLR was slightly elevated in non-survivors compared to survivors, whereas the PLR was higher in survivors, although these differences were not statistically significant. Platelet levels emerged as a predictive factor for mortality, with an AUC of 0.748, a cutoff value of 244.5, and a p-value of 0.002. Additionally, NLR showed a negative correlation with the Glasgow coma score and a positive correlation with age, TLC, CRP, and ALT, with correlation coefficients of (r=-0.253,p = 0.016), (r = 0.320 ,p = 0.002), (r = 0.292,p = 0.005), (r = 0.242 ,p = 0.027), and (r = 0.256 ,p = 0.028) respectively. While no statistically significant relationship was observed between NLR and PLR and non-survivors, platelet count showed moderate discriminatory performance for prognostic evaluation and may be used as part of early risk stratification in critically ill patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.